
Beyond State Scope of Practice Laws for Advanced Practitioners
Additional Supervision Requirements for Buprenorphine Prescribing
Published in: Journal of Substance Abuse Treatment (2022). doi: 10.1016/j.jsat.2021.108715
Posted on RAND.org on March 31, 2022
This study of state buprenorphine prescribing laws found that
- one state prohibits all advanced practice clinicians from prescribing buprenorphine
- five states require a waivered supervising physician for PAs prescribing buprenorphine
- three states require a waivered supervising physician for NPs prescribing buprenorphine.
Studies of state NP/PA supervision should include non-scope of practice laws.
Research conducted by
This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.